Shopping Cart
Remove All
Your shopping cart is currently empty
DO34 is a selective and potent diacylglycerol lipase (DAGL-α/β) inhibitor that impairs fear extinction in mice, and can be used to study lipopolysaccharide inflammatory pain.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $52 | In Stock | In Stock | |
| 5 mg | $123 | In Stock | In Stock | |
| 10 mg | $197 | In Stock | In Stock | |
| 25 mg | $369 | In Stock | In Stock | |
| 50 mg | $546 | In Stock | In Stock | |
| 100 mg | $787 | In Stock | In Stock | |
| 200 mg | $1,070 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $143 | In Stock | In Stock |
| Description | DO34 is a selective and potent diacylglycerol lipase (DAGL-α/β) inhibitor that impairs fear extinction in mice, and can be used to study lipopolysaccharide inflammatory pain. |
| Targets&IC50 | DAGLβ:3-8 nM, DAGLα:6 nM |
| In vitro | DO34 is a potent, selective and centrally active DAGL inhibitor, the efficiency of DAGLα in converting SAG to 2-AG was determined by a real-time fluorescence-based natural substrate assay using membrane lysates from HEK293T cells expressing recombinant human DAGLα, DAGLα IC50 = 6 nM.DO34 is also a potent DAGLβ inhibitor, DAGLβ DO34 is also a potent DAGLβ inhibitor, DAGLβ IC50 = 3-8 nM. [1] |
| In vivo | DO34 reduces 2-AG levels in the brain in a dose- and time-dependent manner and prevents fasting-induced regurgitation in mice, which is typical of cannabinoid CB1 receptor-mediated behavior, and DO34 blocks tonic CB1 activation.DO34 blocks basal PF-EPSCs in AM251-increased MAGL-TKO mice. [2] |
| Molecular Weight | 531.53 |
| Formula | C26H28F3N5O4 |
| Cas No. | 1848233-58-8 |
| Smiles | O=C(OC(C)(C)C)N1CCN(C(=O)N2N=NC(=C2)C=3C=CC(OC(F)(F)F)=CC3)C(CC=4C=CC=CC4)C1 |
| Relative Density. | 1.32 g/cm3 (Predicted) |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (150.51 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 10 mg/mL (18.81 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.